ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
Risk Signals
24754 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Business Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ROCHE DIAGNOSTICS LIMITED
Live alerts from global media, monitored by Business Radar
2023-10-23 (expansion.com)
Public debt rises 4.7% in August to almost 1.6 trillion euros
The total debt of Public Administrations amounts to 1,563 billion euros in August 2023, with a growth rate of 4.7% in interannual terms compared to
Read more
2023-10-19 (biopharmadive.com)
PTC to sell spinal muscular atrophy drug royalties for $1B
A second deal with Royalty Pharma around the Roche therapy Evrysdi will allow PTC to retire Blackstone debt and keep more cash for future operations.
Read more
2023-10-19 (biopharmadive.com)
PTC to sell spinal muscular atrophy drug royalties for $1B
A second deal with Royalty Pharma around the Roche therapy Evrysdi will allow PTC to retire Blackstone debt and keep more cash for future operations.
Read more
2023-10-19 (biopharmadive.com)
PTC to sell spinal muscular atrophy drug royalties for $1B
A second deal with Royalty Pharma around the Roche therapy Evrysdi will allow PTC to retire Blackstone debt and keep more cash for future operations.
Read more